Innovating Works

TcLand

Desconocido
COVIRNA: A diagnostic test to improve surveillance and care of COVID 19 patients FIRALIS MOLECULAR PRECISION S.A. participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 Coronavirus disease 2019 (COVID-19) caused by infection with SARS coronavirus 2 (SARS-CoV-2) has reached pandemic proportions with more than...
2020-10-13 - 2023-04-30 | Financiado
RABIOPRED: RABIOPRED Clinical validation of BIOmarker assay to PREDict treatment response in Rheumatoid Arthr... FIRALIS MOLECULAR PRECISION S.A. tramitó un H2020: H2020-SMEInst-2014-2015 The aim of the RABIOPRED project is to take the final steps to bring an innovative set of biomarkers that is able to predict response to tre...
2015-06-02 - 2018-12-31 | Financiado
BTCURE: BeTheCuRE FIRALIS MOLECULAR PRECISION S.A. participó en un FP6: BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal model...
2011-04-01 - 2017-03-31 | Financiado
HEPTROMIC: Genomic predictors and oncogenic drivers in hepatocellular carcinoma FIRALIS MOLECULAR PRECISION S.A. participó en un FP7: Hepatocellular carcinoma (HCC) accounts for more than 90% of liver cancers, and is a major health problem. Its incidence is growing and with...
Financiado
BTCURE: BeTheCuRE FIRALIS MOLECULAR PRECISION S.A. participó en un FP7: BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal model...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.